JP4515423B2 - Moisturizer, cell activator, and antioxidant - Google Patents
Moisturizer, cell activator, and antioxidant Download PDFInfo
- Publication number
- JP4515423B2 JP4515423B2 JP2006242157A JP2006242157A JP4515423B2 JP 4515423 B2 JP4515423 B2 JP 4515423B2 JP 2006242157 A JP2006242157 A JP 2006242157A JP 2006242157 A JP2006242157 A JP 2006242157A JP 4515423 B2 JP4515423 B2 JP 4515423B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- plant
- pomegranate
- genus
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Toxicology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Biochemistry (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Description
本発明は、保湿剤、細胞賦活剤、及び抗酸化剤に関する。さらに詳しくは、ザクロソウ属植物の抽出物を含有する保湿剤、細胞賦活剤、及び抗酸化剤、並びにザクロソウ属植物の抽出物を含有する皮膚外用剤及び食品に関する。 The present invention relates to a humectant, a cell activator, and an antioxidant. More specifically, the present invention relates to a moisturizer, a cell activator, and an antioxidant containing an extract of a genus Pomegranate plant, and a skin external preparation and food containing an extract of the genus Pomegranate.
加齢、紫外線、ストレスなどによるシワ、シミ、皮膚の弾性低下といった皮膚症状の要因として、乾燥、細胞機能低下、紫外線によるメラニン産生や色素沈着、真皮マトリックス成分の減少や変性、紫外線等による細胞の酸化傷害などが挙げられる。このような皮膚症状を防止・改善するために、様々な有効成分の検索及び配合検討が従来なされてきた。細胞賦活剤としては、ポンカンのエッセンス(特許文献1参照)、抗酸化剤としては、サルオガセ科サルオガセ属植物の抽出物(特許文献2参照)が知られている。 Causes of skin symptoms such as aging, ultraviolet rays, stress, wrinkles, stains, skin elasticity decrease, dryness, decreased cellular function, melanin production and pigmentation due to ultraviolet rays, decrease or degeneration of dermal matrix components, ultraviolet rays, etc. Examples include oxidative damage. In order to prevent and ameliorate such skin symptoms, search for various active ingredients and formulation studies have been conventionally conducted. As the cell activator, the essence of Ponkan (see Patent Document 1) is known, and as the antioxidant, an extract of the plant belonging to the genus Sarogase (see Patent Document 2) is known.
なお、ザクロソウ属植物の抽出物を有効成分とする保湿剤、細胞賦活剤、及び抗酸化剤に関する先行技術は認められなかった。 In addition, the prior art regarding the moisturizer, cell activator, and antioxidant which use the extract of the genus Pomegranate as an active ingredient was not recognized.
天然由来成分は、様々な薬理作用や美容効果を有することが知られ、これまでにも多数の植物や菌類などが皮膚外用剤や飲食品などの分野に幅広く応用されている。しかし、天然由来成分の中には未だその効果が知られていないものも数多く存在し、優れた保湿作用、細胞賦活作用、あるいは抗酸化作用を有する有効成分の開発が期待されていた。本発明は、このような有効成分を見出すためになされたものであり、皮膚外用剤や飲食品などの分野に幅広く応用が可能な保湿剤、細胞賦活剤、及び抗酸化剤を提供することを目的とする。 Naturally-derived components are known to have various pharmacological and cosmetic effects, and so far many plants and fungi have been widely applied to fields such as external preparations for skin and foods and drinks. However, there are many naturally-derived components whose effects are not yet known, and the development of an effective component having an excellent moisturizing action, cell activation action or antioxidant action has been expected. The present invention has been made in order to find such an active ingredient, and provides a moisturizer, a cell activator, and an antioxidant that can be widely applied to fields such as external preparations for skin and foods and drinks. Objective.
本発明者らは、皮膚外用剤や飲食品などの分野に幅広く応用が可能な保湿剤、細胞賦活剤、及び抗酸化剤を見出すために、天然由来の種々の物質について検討を行った。その結果、ザクロソウ属植物の抽出物に優れた保湿作用、細胞賦活作用、及び抗酸化作用を見出し、さらに検討を重ね、本発明を完成するに至った。すなわち、本発明は、ザクロソウ属植物を有効成分とする保湿剤、細胞賦活剤、及び抗酸化剤、並びにザクロソウ属植物の1種または2種以上の植物の抽出物を含有する皮膚外用剤及び食品を提供するものである。 In order to find a moisturizer, a cell activator, and an antioxidant that can be widely applied to fields such as external preparations for skin and foods and drinks, the present inventors have examined various naturally-derived substances. As a result, the present inventors have found a moisturizing action, a cell activation action and an antioxidant action that are excellent in extracts of plants belonging to the genus Pomegranate, and have further studied to complete the present invention. That is, the present invention relates to a skin external preparation and food containing a moisturizer, a cell activator, an antioxidant, and an extract of one or more plants of the genus Pomegranate as an active ingredient. Is to provide.
本発明によれば、優れた効果を有する保湿剤、細胞賦活剤、及び抗酸化剤を提供することができ、これらを皮膚外用剤や食品等の組成物に配合することにより、シワ、タルミ、肌のハリ、シミ、クスミといった種々の皮膚症状の防止や改善に優れた効果を発揮する様々な組成物を提供することができる。 According to the present invention, it is possible to provide a moisturizer, a cell activator, and an antioxidant that have excellent effects. By blending these into a composition such as a skin external preparation or food, wrinkles, tarmi, It is possible to provide various compositions that exhibit an excellent effect in preventing and improving various skin symptoms such as skin firmness, spots, and kusumi.
本発明の原料として用いられる植物であるザクロソウ属(Mollugo)植物は、ザクロソウ(Mollugo pentaphylla)、クルマバザクロソウ(Mollugo verticillata)などが知られている。 As for the plant of the genus Pomegranate ( Mollugo ), which is a plant used as a raw material of the present invention, pomegranate ( Molego pentaphylla ), prunus prunus ( Molgo verticillata ) and the like are known.
本発明に用いられる原料となる植物は、ザクロソウ属植物であれば特に限定されないが、入手が比較的容易であることや有効性などの理由から、ザクロソウを用いることが有効性の点から特に好ましい。 The plant as a raw material used in the present invention is not particularly limited as long as it is a plant belonging to the genus Pomegranate, but it is particularly preferable from the viewpoint of effectiveness to use pomegranate since it is relatively easy to obtain and effective. .
本発明におけるザクロソウ属植物の抽出物には、ザクロソウ属植物の原体や乾燥物も含まれるが、各種溶媒を用いて抽出した抽出物を用いるのが好ましい。抽出には、ザクロソウ属植物の葉、花、種子、根、茎、芽などのいずれの部位を用いても構わないが、簡便に利用するには全草を用いるとよい。抽出の際は、生のまま用いてもよいが、抽出効率を考えると、細切、乾燥、粉砕等の処理を行った後に抽出を行うことが好ましい。抽出は、抽出溶媒に浸漬するか、超臨界流体や亜臨界流体を用いた抽出方法でも行うことができる。抽出効率を上げるため、撹拌や抽出溶媒中でホモジナイズしてもよい。抽出温度としては、5℃程度から抽出溶媒の沸点以下の温度とするのが適切である。抽出時間は抽出溶媒の種類や抽出温度によっても異なるが、1時間〜14日間程度とするのが適切である。 The extract of the genus Pomegranate in the present invention includes the active substance and dried product of the genus Pomegranate, but it is preferable to use an extract extracted using various solvents. For extraction, any part of the leaves, flowers, seeds, roots, stems, buds, etc. of the genus Pomegranate may be used, but whole plants may be used for convenient use. In the extraction, it may be used as it is, but considering the extraction efficiency, it is preferable to perform the extraction after performing processing such as shredding, drying, and pulverization. The extraction can be performed by immersing in an extraction solvent or by an extraction method using a supercritical fluid or a subcritical fluid. In order to increase the extraction efficiency, the mixture may be homogenized in stirring or an extraction solvent. The extraction temperature is suitably about 5 ° C. to the boiling point of the extraction solvent. The extraction time varies depending on the type of extraction solvent and the extraction temperature, but it is appropriate to set it to about 1 hour to 14 days.
抽出溶媒としては、水の他、メタノール、エタノール、プロパノール、イソプロパノール等の低級アルコール、1、3−ブチレングリコール、プロピレングリコール、ジプロピレングリコール、グリセリン等の多価アルコール、エチルエーテル、プロピルエーテル等のエーテル類、酢酸ブチル、酢酸エチル等のエステル類、アセトン、エチルメチルケトン等のケトン類などの溶媒を用いることができ、これらより1種又は2種以上を選択して用いる。また、生理食塩水、リン酸緩衝液、リン酸緩衝生理食塩水等を用いてもよい。さらに、水や二酸化炭素、エチレン、プロピレン、エタノール、メタノール、アンモニアなどの1種又は2種以上の超臨界流体や亜臨界流体を用いてもよい。 Extraction solvents include water, lower alcohols such as methanol, ethanol, propanol and isopropanol, polyhydric alcohols such as 1,3-butylene glycol, propylene glycol, dipropylene glycol and glycerin, ethers such as ethyl ether and propyl ether. And solvents such as esters such as butyl acetate and ethyl acetate, and ketones such as acetone and ethyl methyl ketone can be used, and one or more of these can be selected and used. Further, physiological saline, phosphate buffer, phosphate buffered saline, or the like may be used. Furthermore, you may use 1 type, or 2 or more types of supercritical fluids and subcritical fluids, such as water, a carbon dioxide, ethylene, propylene, ethanol, methanol, ammonia.
ザクロソウ属植物の上記溶媒による抽出物は、そのままでも使用することができるが、濃縮、乾固した物を水や極性溶媒に再度溶解して使用することもでき、これらの生理作用を損なわない範囲で脱色、脱臭、脱塩等の精製処理やカラムクロマトグラフィー等による分画処理を行った後に用いてもよい。ザクロソウ属植物の前記抽出物やその処理物及び分画物は、各処理及び分画後に凍結乾燥し、用時に溶解して用いることもできる。 Extracts from the above-mentioned solvents of the genus Pomegranate can be used as they are, but the concentrated and dried solids can be used again by dissolving them in water or a polar solvent, and their physiological effects are not impaired. It may be used after performing purification treatment such as decolorization, deodorization and desalting, and fractionation treatment by column chromatography. The said extract of the genus Pomegranates, its processed material, and a fraction can also be used after freeze-drying after each processing and fractionation, and melt | dissolving at the time of use.
ザクロソウ属植物の抽出物は、優れた保湿作用、細胞賦活作用、及び抗酸化作用を有し、保湿剤、細胞賦活剤、及び抗酸化剤として利用することができる。また、ザクロソウ属植物の抽出物を有効成分とする保湿剤、細胞賦活剤、及び抗酸化剤は、皮膚に外用する他に、毛髪に使用することや内服することも可能であり、食品、飲料、あるいは医薬品などにも応用することができる。 The extract of the plant of the genus Pomegranate has excellent moisturizing action, cell activation action, and antioxidant action, and can be used as a moisturizing agent, cell activator, and antioxidant. In addition, the moisturizer, cell activator, and antioxidant containing the extract of the plant of the genus Pomegranate as an active ingredient can be used on the hair or taken orally, as well as applied to the skin. Or it can be applied to pharmaceuticals.
ザクロソウ属植物の抽出物を有効成分とする保湿剤は、皮膚や毛髪に対して優れた保湿作用を発揮し、特に皮膚に対する保湿効果が高い。 A moisturizing agent containing an extract of the genus Pomegranate as an active ingredient exhibits an excellent moisturizing action on the skin and hair, and has a particularly high moisturizing effect on the skin.
ザクロソウ属植物の抽出物を有効成分とする細胞賦活剤は、種々の細胞に対して優れた賦活作用を発揮するが、特に真皮線維芽細胞に対して優れた効果を発揮する。 Although the cell activator which uses the extract of the genus Pomegranate plant as an active ingredient exhibits the outstanding activation effect | action with respect to various cells, especially exhibits the outstanding effect with respect to a dermal fibroblast.
ザクロソウ属植物の抽出物を有効成分とする抗酸化剤は、優れた抗酸化作用を発揮するが、特にフリーラジカル消去作用に優れた効果を発揮する。 An antioxidant comprising an extract of the genus Pomegranate as an active ingredient exhibits an excellent antioxidant action, but particularly exhibits an excellent free radical scavenging action.
また、ザクロソウ属植物の抽出物を皮膚外用剤に配合することにより、シワ、タルミ、肌のハリ、シミ、クスミ、乾燥、小じわ等の皮膚症状の防止・改善に優れた効果を発揮する皮膚外用剤を得ることができ、保湿用皮膚外用剤、美白用皮膚外用剤、あるいは老化防止改善用皮膚外用剤として用いることができる。さらに、ザクロソウ属植物の抽出物は、美容、健康維持、又は栄養補給を目的とするような食品にも用いることもできる。なお、本発明の食品には飲料も含まれる。 In addition, by adding the extract of the plant of the genus Pomegranate to the external preparation for skin, it can be used externally for skin to prevent and improve skin symptoms such as wrinkles, tarmi, skin firmness, spots, kumi, dryness and fine lines. And can be used as a moisturizing skin external preparation, a whitening skin external preparation, or an anti-aging skin external preparation. Furthermore, the extract of the genus Pomegranate can also be used for foods intended for beauty, health maintenance or nutritional supplementation. In addition, a drink is also contained in the foodstuff of this invention.
ザクロソウ属植物の抽出物を皮膚外用剤に配合する際の配合量は、皮膚外用剤の種類や使用目的等によって調整することができるが、効果や安定性などの点から、全量に対して0.0001〜50.0重量%が好ましく、より好ましくは、0.001〜25.0重量%である。 The amount of the extract of the genus Pomegranate belonging to the external preparation for skin can be adjusted according to the kind of external preparation for external use and the purpose of use. 0.0001 to 50.0% by weight is preferable, and 0.001 to 25.0% by weight is more preferable.
ザクロソウ属植物の抽出物を配合する皮膚外用剤の剤型は任意であり、例えば、ローションなどの可溶化系、クリームや乳液などの乳化系、カラミンローション等の分散系として提供することができる。さらに、噴射剤と共に充填したエアゾール、軟膏剤、粉末、顆粒などの種々の剤型で提供することもできる。 The dosage form of the external preparation for skin containing the extract of the genus Pomegranate is arbitrary, and can be provided, for example, as a solubilizing system such as lotion, an emulsifying system such as cream or emulsion, or a dispersing system such as calamine lotion. Furthermore, it can also be provided in various dosage forms such as aerosols, ointments, powders and granules filled with a propellant.
なお、ザクロソウ属植物の抽出物を配合する皮膚外用剤には、ザクロソウ属植物の抽出物の他に、必要に応じて、通常医薬品、医薬部外品、皮膚化粧料、毛髪用化粧料及び洗浄料に配合される、油性成分、保湿剤、粉体、色素、乳化剤、可溶化剤、洗浄剤、紫外線吸収剤、増粘剤、薬剤、香料、樹脂、防菌防黴剤、アルコール類等を適宜配合することができる。また、本発明の効果を損なわない範囲において、他の保湿剤、細胞賦活剤、あるいは抗酸化剤との併用も可能である。 In addition, for the topical skin preparation containing the extract of the genus Pomegranate, in addition to the extract of the genus Pomegranate, in addition to the extract of the genus Pomegranate, if necessary, it is usually a pharmaceutical, a quasi-drug, skin cosmetic, hair cosmetic and washing Oil components, moisturizers, powders, pigments, emulsifiers, solubilizers, cleaning agents, UV absorbers, thickeners, drugs, fragrances, resins, antibacterial and antifungal agents, alcohols, etc. It can mix | blend suitably. Moreover, in the range which does not impair the effect of this invention, combined use with another moisturizer, a cell activator, or an antioxidant is also possible.
以下にザクロソウ属植物の抽出物の製造例、各作用を評価するための試験、皮膚外用剤や食品としての処方例、使用試験についてさらに詳細に説明するが、本発明の技術的範囲はこれによってなんら限定されるものではない。 In the following, production examples of extracts of the genus Pomegranates, tests for evaluating each action, examples of formulations for skin external preparations and foods, and use tests will be described in more detail, but the technical scope of the present invention is It is not limited at all.
[製造例1]
ザクロソウ属植物の乾燥粉砕物1kgに50重量%エタノール水溶液を10リットル加え、室温で7日間浸漬した。抽出液をろ過して回収し、溶媒を除去した後、ザクロソウ属植物の抽出物を得た。
[Production Example 1]
10 kg of a 50 wt% aqueous ethanol solution was added to 1 kg of a dry pulverized product of the genus Pomegranate and immersed for 7 days at room temperature. The extract was collected by filtration, and after removing the solvent, an extract of the plant of the genus Pomegranate was obtained.
[製造例2]
ザクロソウ属植物の乾燥粉砕物1kgに水を9リットル加え、90℃にて6時間還流して抽出した。抽出液をろ過して回収し、溶媒を除去した後、ザクロソウ属植物の抽出物を得た。
[Production Example 2]
Nine liters of water was added to 1 kg of a dried pulverized plant of the genus Pomegranate and extracted by refluxing at 90 ° C. for 6 hours. The extract was collected by filtration, and after removing the solvent, an extract of the plant of the genus Pomegranate was obtained.
[製造例3]
ザクロソウ属植物の乾燥粉砕物1kgにメタノールを9リットル加え、室温で7日間浸漬した。抽出液をろ過して回収し、溶媒を除去した後、ザクロソウ属植物の抽出物を得た。
[Production Example 3]
Nine liters of methanol was added to 1 kg of a dry pulverized product of the genus Pomegranate and immersed for 7 days at room temperature. The extract was collected by filtration, and after removing the solvent, an extract of the plant of the genus Pomegranate was obtained.
[製造例4]
超臨界抽出装置にザクロソウ属植物を投入し、40℃において15MPaの気圧下で二酸化炭素の超臨界流体を用いて抽出した。抽出物を回収し、ザクロソウ属植物の抽出物を得た。
[Production Example 4]
The plant of the genus Pomegranate was introduced into a supercritical extraction apparatus, and extracted using a supercritical fluid of carbon dioxide at 40 ° C. under a pressure of 15 MPa. The extract was collected to obtain an extract of the plant of the genus Pomegranate.
まず、ザクロソウ属植物の抽出物の細胞賦活作用について示す。試料には、ザクロソウの全草を製造例1により抽出したものを試料として評価を行った。 First, it shows about the cell activation effect of the extract of a genus Pomegranate. The sample was evaluated by extracting the whole plant of pomegranate according to Production Example 1 as a sample.
評価は、以下の手順で行った。正常ヒト真皮線維芽細胞を1ウェル当たり2.0×104個となるように96穴マイクロプレートに播種した。播種培地には、ダルベッコ改変イーグル培地(DMEM)に1%のウシ胎児血清を添加したものを用いた。24時間培養後、任意の濃度の試料を添加した試験培地に交換し、さらに48時間培養した。次いで3−(4,5−ジメチル−2−チアゾリル)−2,5−ジフェニルテトラゾリウムブロミド(MTT)を400μg/mL含有する培地に交換して2時間培養し、テトラゾリウム環の開環により生じるフォルマザンを2−プロパノールにて抽出し、マイクロプレートリーダーにて550nmの吸光度を測定した。同時に濁度として650nmにおける吸光度を測定し、両測定値の差により細胞賦活作用を評価した。評価結果を、試料無添加のブランクにおける細胞賦活作用を100とした相対値にて表1に示す。なお、表中の*及び**は、t検定における有意確率P値に対し、有意確率1%未満(P<0.05)を*で有意確率1%未満(P<0.01)を**で表したものである。 The evaluation was performed according to the following procedure. Normal human dermal fibroblasts were seeded in a 96-well microplate at 2.0 × 10 4 cells per well. The seeding medium used was Dulbecco's modified Eagle medium (DMEM) supplemented with 1% fetal bovine serum. After culturing for 24 hours, the culture medium was replaced with a test medium to which a sample having an arbitrary concentration was added, and further cultured for 48 hours. Next, the medium containing 400 μg / mL of 3- (4,5-dimethyl-2-thiazolyl) -2,5-diphenyltetrazolium bromide (MTT) was exchanged and cultured for 2 hours. Formazan generated by the opening of the tetrazolium ring was removed. Extraction was performed with 2-propanol, and absorbance at 550 nm was measured with a microplate reader. At the same time, the absorbance at 650 nm was measured as turbidity, and the cell activation effect was evaluated by the difference between the two measured values. The evaluation results are shown in Table 1 as relative values with the cell activation effect in the blank with no sample as 100. In the table, * and ** indicate a significance probability of less than 1% (P <0.05) and a significance probability of less than 1% (P <0.01), respectively, with respect to the significance P value in the t test. This is indicated by *.
表1より明らかなように、ザクロソウ属植物の抽出物を添加した培地では、有意な真皮線維芽細胞賦活作用が認められた。このことから、ザクロソウ属植物の抽出物は、優れた細胞賦活作用を有することが明らかとなった。 As is clear from Table 1, a significant dermal fibroblast activation effect was observed in the medium to which the extract of the genus Pomegranate was added. From this, it became clear that the extract of the plant of the genus Pomegranate has an excellent cell activation effect.
次に、ザクロソウ属植物の抽出物の抗酸化作用について示す。試料には、ザクロソウの全草を製造例1により抽出したものを試料として評価を行った。 Next, the antioxidant effect of the extract of the genus Pomegranate is shown. The sample was evaluated by extracting the whole plant of pomegranate according to Production Example 1 as a sample.
評価は、以下の手順で行った。50重量%エタノール水溶液にて任意の濃度に希釈した試料を96穴マイクロプレートに100μL添加した。次に、0.2mMの濃度になるようにエタノールにて調製した1、1−ジフェニル−2−ピクリルヒドラジル(DPPH)溶液を96穴マイクロプレートに100μL添加した。攪拌しながら暗所に放置し、24時間後に516nmの吸光度を測定した。試料が無添加のブランクの吸光度を(A)、試料を添加したときの吸光度を(B)としたとき、式(1)の値をラジカル消去率とした。評価結果を表2に示した。
式(1) {1−(B)/(A)}×100(%)
The evaluation was performed according to the following procedure. 100 μL of a sample diluted to an arbitrary concentration with a 50 wt% aqueous ethanol solution was added to a 96-well microplate. Next, 100 μL of a 1,1-diphenyl-2-picrylhydrazyl (DPPH) solution prepared with ethanol to a concentration of 0.2 mM was added to a 96-well microplate. The mixture was left in the dark with stirring, and the absorbance at 516 nm was measured after 24 hours. When the absorbance of the blank with no sample added was (A) and the absorbance when the sample was added was (B), the value of formula (1) was defined as the radical elimination rate. The evaluation results are shown in Table 2.
Formula (1) {1- (B) / (A)} × 100 (%)
表2より明らかなように、ザクロソウ属植物の抽出物はラジカル消去に基づく抗酸化作用を有することが分かった。 As is clear from Table 2, it was found that the extract of the plant of the genus Pomegranate has an antioxidant action based on radical scavenging.
続いて、本発明に係るザクロソウ属植物の抽出物を配合した皮膚外用剤と食品の処方例を示す。 Then, the formulation example of the skin external preparation and the foodstuff which mix | blended the extract of the Pomegranates genus plant based on this invention is shown.
[処方例1]乳液
(1)スクワラン 10.0(重量%)
(2)メチルフェニルポリシロキサン 4.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)モノステアリン酸ポリオキシエチレン
ソルビタン(20E.O.) 1.3
(6)モノステアリン酸ソルビタン 1.0
(7)グリセリン 4.0
(8)パラオキシ安息香酸メチル 0.1
(9)カルボキシビニルポリマー 0.15
(10)精製水 57.85
(11)アルギニン(1重量%水溶液) 20.0
(12)ザクロソウ属植物の抽出物[製造例1] 1.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、冷却を開始し、(11)と(12)を順次加え、均一に混合する。
[Formulation Example 1] Emulsion (1) Squalane 10.0 (wt%)
(2) Methylphenylpolysiloxane 4.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Polyoxyethylene monostearate
Sorbitan (20E.O.) 1.3
(6) Sorbitan monostearate 1.0
(7) Glycerin 4.0
(8) Methyl paraoxybenzoate 0.1
(9) Carboxyvinyl polymer 0.15
(10) Purified water 57.85
(11) Arginine (1 wt% aqueous solution) 20.0
(12) Extract of Pomegranates plant [Production Example 1] 1.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After emulsification, start cooling and add (11) and (12) sequentially and mix uniformly.
[処方例2]化粧水
(1)エタノール 15.0(重量%)
(2)ポリオキシエチレン(40E.O.)硬化ヒマシ油 0.3
(3)香料 0.1
(4)精製水 82.38
(5)クエン酸 0.02
(6)クエン酸ナトリウム 0.1
(7)グリセリン 1.0
(8)ヒドロキシエチルセルロース 0.1
(9)ザクロソウ属植物の抽出物[製造例3] 1.0
製法:(1)に(2)及び(3)を溶解する。溶解後、(4)〜(8)を順次添加した後、十分に攪拌し、(9)を加え、均一に混合する。
[Prescription Example 2] Lotion (1) Ethanol 15.0 (% by weight)
(2) Polyoxyethylene (40E.O.) hydrogenated castor oil 0.3
(3) Fragrance 0.1
(4) Purified water 82.38
(5) Citric acid 0.02
(6) Sodium citrate 0.1
(7) Glycerin 1.0
(8) Hydroxyethyl cellulose 0.1
(9) Extract of Pomegranates plant [Production Example 3] 1.0
Production method: (2) and (3) are dissolved in (1). After dissolution, (4) to (8) are sequentially added, and then sufficiently stirred, (9) is added and mixed uniformly.
[処方例3]クリーム
(1)スクワラン 10.0(重量%)
(2)ステアリン酸 2.0
(3)水素添加パーム核油 0.5
(4)水素添加大豆リン脂質 0.1
(5)セタノール 3.6
(6)親油型モノステアリン酸グリセリン 2.0
(7)グリセリン 10.0
(8)パラオキシ安息香酸メチル 0.1
(9)アルギニン(20重量%水溶液) 15.0
(10)精製水 40.7
(11)カルボキシビニルポリマー(1重量%水溶液) 15.0
(12)ザクロソウ属植物の抽出物[製造例1] 1.0
製法:(1)〜(6)の油相成分を80℃にて加熱溶解する。一方(7)〜(10)の水相成分を80℃にて加熱溶解する。これに前記油相成分を攪拌しながら加え、ホモジナイザーにより均一に乳化する。乳化終了後、(11)を加え、冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Prescription Example 3] Cream (1) Squalane 10.0 (% by weight)
(2) Stearic acid 2.0
(3) Hydrogenated palm kernel oil 0.5
(4) Hydrogenated soybean phospholipid 0.1
(5) Cetanol 3.6
(6) Lipophilic glyceryl monostearate 2.0
(7) Glycerin 10.0
(8) Methyl paraoxybenzoate 0.1
(9) Arginine (20% by weight aqueous solution) 15.0
(10) Purified water 40.7
(11) Carboxyvinyl polymer (1% by weight aqueous solution) 15.0
(12) Extract of Pomegranates plant [Production Example 1] 1.0
Production method: The oil phase components (1) to (6) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 80 ° C. The oil phase component is added to this while stirring and uniformly emulsified with a homogenizer. After the emulsification is completed, add (11), start cooling, add (12) at 40 ° C., and mix uniformly.
[処方例4]美容液
(1)精製水 27.45(重量%)
(2)グリセリン 14.0
(3)ショ糖脂肪酸エステル 1.3
(4)カルボキシビニルポリマー(1重量%水溶液) 17.5
(5)アルギン酸ナトリウム(1重量%水溶液) 15.0
(6)モノラウリン酸ポリグリセリル 1.0
(7)マカデミアナッツ油脂肪酸フィトステリル 3.0
(8)N-ラウロイル-L-グルタミン酸
ジ(フィトステリル−2−オクチルドデシル) 2.0
(9)硬化パーム油 2.0
(10)スクワラン(オリーブ由来) 1.0
(11)ベヘニルアルコール 0.75
(12)ミツロウ 1.0
(13)ホホバ油 1.0
(14)1、3−ブチレングリコール 10.0
(15)L−アルギニン(10重量%水溶液) 2.0
(16)ザクロソウ属植物の抽出物[製造例1] 1.0
製法:(1)〜(6)の水相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(14)の油相成分を混合し、75℃にて加熱溶解する。次いで、上記水相成分に油相成分を添加して予備乳化を行った後、ホモミキサーにて均一に乳化する。乳化終了後に冷却を開始し、50℃にて(15)を加える。さらに40℃まで冷却し、(16)を加え、均一に混合する。
[Formulation Example 4] Cosmetic liquid (1) Purified water 27.45 (% by weight)
(2) Glycerol 14.0
(3) Sucrose fatty acid ester 1.3
(4) Carboxyvinyl polymer (1% by weight aqueous solution) 17.5
(5) Sodium alginate (1 wt% aqueous solution) 15.0
(6) Polyglyceryl monolaurate 1.0
(7) Macadamia nut oil fatty acid phytosteryl 3.0
(8) N-lauroyl-L-glutamic acid di (phytosteryl-2-octyldodecyl) 2.0
(9) Hardened palm oil 2.0
(10) Squalane (from olive) 1.0
(11) Behenyl alcohol 0.75
(12) Beeswax 1.0
(13) Jojoba oil 1.0
(14) 1,3-butylene glycol 10.0
(15) L-arginine (10% by weight aqueous solution) 2.0
(16) Extract of Pomegranates [Production Example 1] 1.0
Production method: The aqueous phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the oil phase components (7) to (14) are mixed and dissolved by heating at 75 ° C. Next, the oil phase component is added to the aqueous phase component and preliminary emulsification is performed, followed by uniform emulsification with a homomixer. Cooling is started after completion of emulsification, and (15) is added at 50 ° C. Cool further to 40 ° C, add (16) and mix evenly.
[処方例5]水性ジェル
(1)カルボキシビニルポリマー 0.5(重量%)
(2)精製水 86.7
(3)水酸化ナトリウム(10重量%水溶液) 0.5
(4)エタノール 10.0
(5)パラオキシ安息香酸メチル 0.1
(6)香料 0.1
(7)ザクロソウ属植物の抽出物[製造例4] 2.0
(8)ポリオキシエチレン(60E.O.)硬化ヒマシ油 0.1
製法:(1)を(2)に加え、均一に攪拌した後、(3)を加える。均一に攪拌した後、(4)に予め溶解した(5)を加える。均一に攪拌した後、予め混合しておいた(6)〜(8)を加え、均一に攪拌混合する。
[Formulation Example 5] Aqueous gel (1) Carboxyvinyl polymer 0.5 (% by weight)
(2) Purified water 86.7
(3) Sodium hydroxide (10% by weight aqueous solution) 0.5
(4) Ethanol 10.0
(5) Methyl paraoxybenzoate 0.1
(6) Fragrance 0.1
(7) Extract of Pomegranates plant [Production Example 4] 2.0
(8) Polyoxyethylene (60E.O.) hydrogenated castor oil 0.1
Manufacturing method: (1) is added to (2), and after stirring uniformly, (3) is added. After stirring uniformly, (5) previously dissolved in (4) is added. After stirring uniformly, the previously mixed (6) to (8) are added and stirred and mixed uniformly.
[処方例6]クレンジング料
(1)スクワラン 81.0(重量%)
(2)イソステアリン酸ポリオキシエチレングリセリル 15.0
(3)精製水 3.0
(4)ザクロソウ属植物の抽出物[製造例4] 1.0
製法:(1)と(2)を均一に溶解する。これに、(3)と(4)を順次加え、均一に混合する。
[Formulation Example 6] Cleansing Fee (1) Squalane 81.0 (wt%)
(2) Polyoxyethylene glyceryl isostearate 15.0
(3) Purified water 3.0
(4) Extract of Pomegranate plant [Production Example 4] 1.0
Manufacturing method: (1) and (2) are uniformly dissolved. (3) and (4) are sequentially added to this and mixed uniformly.
[処方例7]洗顔フォーム
(1)ステアリン酸 16.0(重量%)
(2)ミリスチン酸 16.0
(3)親油型モノステアリン酸グリセリン 2.0
(4)グリセリン 20.0
(5)水酸化ナトリウム 7.5
(6)ヤシ油脂肪酸アミドプロピルベタイン 1.0
(7)精製水 36.5
(8)ザクロソウ属植物の抽出物[製造例3] 1.0
製法:(1)〜(4)の油相成分を80℃にて加熱溶解する。一方(5)〜(7)の水相成分を80℃にて加熱溶解し、油相成分と均一に混合撹拌する。冷却を開始し、40℃にて(8)を加え、均一に混合する。
[Prescription Example 7] Face-wash foam (1) Stearic acid 16.0 (% by weight)
(2) Myristic acid 16.0
(3) Lipophilic glyceryl monostearate 2.0
(4) Glycerin 20.0
(5) Sodium hydroxide 7.5
(6) Palm oil fatty acid amidopropyl betaine 1.0
(7) Purified water 36.5
(8) Pomegranate plant extract [Production Example 3] 1.0
Production method: The oil phase components (1) to (4) are heated and dissolved at 80 ° C. On the other hand, the aqueous phase components (5) to (7) are heated and dissolved at 80 ° C., and mixed and stirred uniformly with the oil phase components. Cooling is started, and (8) is added at 40 ° C. and mixed uniformly.
[処方例8]メイクアップベースクリーム
(1)スクワラン 10.0(重量%)
(2)セタノール 2.0
(3)グリセリントリ−2−エチルヘキサン酸エステル 2.5
(4)親油型モノステアリン酸グリセリル 1.0
(5)プロピレングリコール 11.0
(6)ショ糖脂肪酸エステル 1.3
(7)精製水 69.4
(8)酸化チタン 1.0
(9)ベンガラ 0.1
(10)黄酸化鉄 0.4
(11)香料 0.1
(12)ザクロソウ属植物の抽出物[製造例2] 1.2
製法:(1)〜(4)の油相成分を混合し、75℃にて加熱溶解する。一方、(5)〜(7)の水相成分を混合し、75℃にて加熱溶解し、これに(8)〜(10)の顔料を加え、ホモミキサーにて均一に分散させる。この水相成分に前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Prescription Example 8] Make-up base cream (1) Squalane 10.0 (% by weight)
(2) Cetanol 2.0
(3) Glycerin tri-2-ethylhexanoate 2.5
(4) Lipophilic glyceryl monostearate 1.0
(5) Propylene glycol 11.0
(6) Sucrose fatty acid ester 1.3
(7) Purified water 69.4
(8) Titanium oxide 1.0
(9) Bengala 0.1
(10) Yellow iron oxide 0.4
(11) Fragrance 0.1
(12) Extract of Pomegranate plant [Production Example 2] 1.2
Production method: The oil phase components (1) to (4) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (5) to (7) are mixed and dissolved by heating at 75 ° C., and the pigments (8) to (10) are added thereto and dispersed uniformly with a homomixer. The oil phase component is added to the water phase component and emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.
[処方例9]乳液状ファンデーション
(1)メチルポリシロキサン 2.0(重量%)
(2)スクワラン 5.0
(3)ミリスチン酸オクチルドデシル 5.0
(4)セタノール 1.0
(5)ポリオキシエチレン(20E.O.)
ソルビタンモノステアリン酸エステル 1.3
(6)モノステアリン酸ソルビタン 0.7
(7)1、3−ブチレングリコール 8.0
(8)キサンタンガム 0.1
(9)パラオキシ安息香酸メチル 0.1
(10)精製水 57.4
(11)酸化チタン 9.0
(12)タルク 7.4
(13)ベンガラ 0.5
(14)黄酸化鉄 1.1
(15)黒酸化鉄 0.1
(16)香料 0.1
(17)ザクロソウ属植物の抽出物[製造例4] 1.0
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解する。一方、(7)〜(10)の水相成分を混合し、75℃にて加熱溶解し、これに(11)〜(15)の顔料を加え、ホモミキサーにて均一に分散する。油相成分を加え、乳化を行う。乳化終了後に冷却を開始し、40℃にて(16)と(17)の成分を順次加え、均一に混合する。
[Formulation Example 9] Emulsion foundation (1) Methylpolysiloxane 2.0 (wt%)
(2) Squalane 5.0
(3) Octyldodecyl myristate 5.0
(4) Cetanol 1.0
(5) Polyoxyethylene (20E.O.)
Sorbitan monostearate 1.3
(6) Sorbitan monostearate 0.7
(7) 1,3-butylene glycol 8.0
(8) Xanthan gum 0.1
(9) Methyl paraoxybenzoate 0.1
(10) Purified water 57.4
(11) Titanium oxide 9.0
(12) Talc 7.4
(13) Bengala 0.5
(14) Yellow iron oxide 1.1
(15) Black iron oxide 0.1
(16) Fragrance 0.1
(17) Extract of Pomegranates plant [Production Example 4] 1.0
Production method: The oil phase components (1) to (6) are mixed and dissolved by heating at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are mixed and dissolved by heating at 75 ° C., and the pigments (11) to (15) are added thereto and uniformly dispersed with a homomixer. Add oil phase ingredients and emulsify. Cooling is started after the emulsification is completed, and components (16) and (17) are sequentially added at 40 ° C. and mixed uniformly.
[処方例10]油中水型エモリエントクリーム
(1)流動パラフィン 30.0(重量%)
(2)マイクロクリスタリンワックス 2.0
(3)ワセリン 5.0
(4)ジグリセリンオレイン酸エステル 5.0
(5)塩化ナトリウム 1.3
(6)塩化カリウム 0.1
(7)プロピレングリコール 3.0
(8)1、3−ブチレングリコール 5.0
(9)パラオキシ安息香酸メチル 0.1
(10)ザクロソウ属植物の抽出物[製造例1] 1.0
(11)精製水 47.4
(12)香料 0.1
製法:(5)と(6)を(11)の一部に溶解して50℃とし、50℃に加熱した(4)に撹拌しながら徐々に加える。これを混合した後、70℃にて加熱溶解した(1)〜(3)に均一に分散する。これに(7)〜(10)を(11)の残部に70℃にて加熱溶解したものを撹拌しながら加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(12)を加え、均一に混合する。
[Formulation Example 10] Water-in-oil emollient cream (1) Liquid paraffin 30.0 (% by weight)
(2) Microcrystalline wax 2.0
(3) Vaseline 5.0
(4) Diglycerin oleate 5.0
(5) Sodium chloride 1.3
(6) Potassium chloride 0.1
(7) Propylene glycol 3.0
(8) 1,3-butylene glycol 5.0
(9) Methyl paraoxybenzoate 0.1
(10) Extract of Pomegranates [Production Example 1] 1.0
(11) Purified water 47.4
(12) Fragrance 0.1
Production method: Dissolve (5) and (6) in a part of (11) to 50 ° C., and gradually add to (4) heated to 50 ° C. with stirring. After mixing this, it disperse | distributes uniformly to (1)-(3) heated and melt | dissolved at 70 degreeC. (7) to (10) are added to the remainder of (11) heated and dissolved at 70 ° C. while stirring, and emulsified with a homomixer. Cooling is started after completion of emulsification, and (12) is added at 40 ° C. and mixed uniformly.
[処方例11]パック
(1)精製水 62.9(重量%)
(2)ポリビニルアルコール 12.0
(3)エタノール 17.0
(4)グリセリン 5.0
(5)ポリエチレングリコール(平均分子量1000) 2.0
(6)ザクロソウ属植物の抽出物[製造例2] 1.0
(7)香料 0.1
製法:(2)と(3)を混合し、80℃に加温した後、80℃に加温した(1)に溶解する。均一に溶解した後、(4)と(5)を加え、攪拌しながら冷却を開始する。40℃まで冷却し、(6)と(7)を加え、均一に混合する。
[Prescription Example 11] Pack (1) Purified water 62.9 (% by weight)
(2) Polyvinyl alcohol 12.0
(3) Ethanol 17.0
(4) Glycerin 5.0
(5) Polyethylene glycol (average molecular weight 1000) 2.0
(6) Extract of Pomegranate plant [Production Example 2] 1.0
(7) Fragrance 0.1
Production method: (2) and (3) are mixed, heated to 80 ° C, and then dissolved in (1) heated to 80 ° C. After uniformly dissolving, add (4) and (5), and start cooling while stirring. Cool to 40 ° C, add (6) and (7) and mix uniformly.
[処方例12]入浴剤
(1)香料 0.3(重量%)
(2)ザクロソウ属植物の抽出物[製造例1] 1.0
(3)炭酸水素ナトリウム 50.0
(4)硫酸ナトリウム 48.7
製法:(1)〜(4)を均一に混合する。
[Prescription Example 12] Bath agent (1) Fragrance 0.3 (% by weight)
(2) Extract of Pomegranates plant [Production Example 1] 1.0
(3) Sodium bicarbonate 50.0
(4) Sodium sulfate 48.7
Production method: (1) to (4) are mixed uniformly.
[処方例13]ヘアーワックス
(1)ステアリン酸 3.0(重量%)
(2)マイクロクリスタリンワックス 2.0
(3)セチルアルコール 3.0
(4)高重合メチルポリシロキサン 2.0
(5)メチルポリシロキサン 5.0
(6)ポリ(オキシエチレン・オキシプロピレン)
メチルポリシロキサン共重合体 1.0
(7)パラオキシ安息香酸メチル 0.1
(8)1、3−ブチレングリコール 7.5
(9)アルギニン 0.7
(10)精製水 74.6
(11)ザクロソウ属植物の抽出物[製造例1] 1.0
(12)香料 0.1
製法:(1)〜(6)の油相成分を混合し、75℃にて加熱溶解後する。一方、(7)〜(10)の水相成分を75℃にて加熱溶解し、前記油相成分を加え、ホモミキサーにて乳化する。乳化終了後に冷却を開始し、40℃にて(11)と(12)の成分を加え、均一に混合する。
[Prescription Example 13] Hair wax (1) Stearic acid 3.0 (% by weight)
(2) Microcrystalline wax 2.0
(3) Cetyl alcohol 3.0
(4) Highly polymerized methylpolysiloxane 2.0
(5) Methylpolysiloxane 5.0
(6) Poly (oxyethylene / oxypropylene)
Methylpolysiloxane copolymer 1.0
(7) Methyl paraoxybenzoate 0.1
(8) 1,3-butylene glycol 7.5
(9) Arginine 0.7
(10) Purified water 74.6
(11) Extract of Pomegranates plant [Production Example 1] 1.0
(12) Fragrance 0.1
Production method: The oil phase components (1) to (6) are mixed and heated and dissolved at 75 ° C. On the other hand, the aqueous phase components (7) to (10) are dissolved by heating at 75 ° C., the oil phase component is added, and the mixture is emulsified with a homomixer. Cooling is started after the emulsification is completed, and the components (11) and (12) are added at 40 ° C. and mixed uniformly.
[処方例14]ヘアートニック
(1)エタノール 50.0(重量%)
(2)精製水 48.9
(3)ザクロソウ属植物の抽出物[製造例3] 1.0
(4)香料 0.1
製法:(1)〜(4)の成分を混合、均一化する。
[Prescription Example 14] Hair artic (1) Ethanol 50.0 (% by weight)
(2) Purified water 48.9
(3) Extract of Pomegranates plant [Production Example 3] 1.0
(4) Fragrance 0.1
Production method: Components (1) to (4) are mixed and homogenized.
[処方例15]錠剤
(1)ザクロソウ属植物の抽出物[製造例1] 100.0(mg)
(2)還元麦芽糖水飴 461.0
(3)トウモロコシデンプン 15.0
(4)グリセリン脂肪酸エステル 12.0
(5)香料 12.0
製法:(1)〜(3)をそれぞれ篩過して混合し、次いで、(4)〜(5)を添加して混合した。その後、常法により打錠して、全量が600mgの錠剤を得た。
[Prescription Example 15] Tablet (1) Extract of plant of the genus Pomegranate [Production Example 1] 100.0 (mg)
(2) Reduced maltose starch syrup 461.0
(3) Corn starch 15.0
(4) Glycerin fatty acid ester 12.0
(5) Fragrance 12.0
Production method: (1) to (3) were respectively sieved and mixed, and then (4) to (5) were added and mixed. Thereafter, tableting was performed by a conventional method to obtain a tablet having a total amount of 600 mg.
次に、ザクロソウ属植物の抽出物を配合した処方を用いて使用試験を行い、乾燥による肌荒れについて改善効果を評価した。その際、処方例1に示した乳液の処方に表3に記載するザクロソウ属植物の抽出物をそれぞれ配合し、実施例1〜2として使用試験を行った。また、ザクロソウ属植物の抽出物を精製水に代替し、比較例1として同時に使用試験を行った。 Next, a use test was conducted using a formulation containing an extract of the genus Pomegranate, and the effect of improving the rough skin due to drying was evaluated. At that time, the extract of the genus Pomegranate listed in Table 3 was added to the formulation of the emulsion shown in Formulation Example 1, and the use test was conducted as Examples 1-2. Moreover, the extract of the plant of the genus Pomegranate was replaced with purified water, and a use test was simultaneously conducted as Comparative Example 1.
各試料について、肌荒れ症状が顕著に認められる30〜50才代の乾燥肌の女性パネラー20名をそれぞれ一群とし、ブラインドにて1週間使用させ、使用前後の皮膚状態の変化を観察して評価した。皮膚症状の指標として、乾燥による肌荒れについて、「改善」、「やや改善」、「変化なし」の三段階で評価し、表4に各評価を得たパネラー数にて示した。 For each sample, 20 female panelists with dry skin in their 30s to 50s whose skin symptom was remarkably recognized were grouped and used for one week blindly, and the skin condition before and after use was observed and evaluated. . As an index of skin symptoms, rough skin due to dryness was evaluated in three stages of “improvement”, “slight improvement”, and “no change”, and Table 4 shows the number of panelists that obtained each evaluation.
表4より、ザクロソウ属植物の抽出物を含有しない比較例使用群においては、7割以上のパネラーに改善は認められなかったが、ザクロソウ属植物の抽出物を配合した実施例使用群においては、7割以上のパネラーに明確な肌荒れの改善が認められた。このことから、ザクロソウ属植物の抽出物は優れた保湿効果を有することが明らかとなった。 From Table 4, in the comparative example use group not containing the extract of the genus Pomegranate plant, improvement was not recognized in 70% or more of the panelers, but in the example use group containing the extract of the genus Pomegranate, More than 70% of panelists showed a clear improvement in rough skin. From this, it became clear that the extract of the plant of the genus Pomegranate has an excellent moisturizing effect.
Claims (1)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006242157A JP4515423B2 (en) | 2006-09-06 | 2006-09-06 | Moisturizer, cell activator, and antioxidant |
PCT/JP2007/067405 WO2008029879A1 (en) | 2006-09-06 | 2007-09-06 | Moisturizing agent, cell-activating agent and antioxidant |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006242157A JP4515423B2 (en) | 2006-09-06 | 2006-09-06 | Moisturizer, cell activator, and antioxidant |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008063273A JP2008063273A (en) | 2008-03-21 |
JP4515423B2 true JP4515423B2 (en) | 2010-07-28 |
Family
ID=39157304
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006242157A Active JP4515423B2 (en) | 2006-09-06 | 2006-09-06 | Moisturizer, cell activator, and antioxidant |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4515423B2 (en) |
WO (1) | WO2008029879A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2012232976A (en) * | 2011-04-18 | 2012-11-29 | Toyo Shinyaku Co Ltd | Whitening composition, skin-care preparation for external use and food and drink which each contain the same, and method for producing the whitening composition |
-
2006
- 2006-09-06 JP JP2006242157A patent/JP4515423B2/en active Active
-
2007
- 2007-09-06 WO PCT/JP2007/067405 patent/WO2008029879A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008029879A1 (en) | 2008-03-13 |
JP2008063273A (en) | 2008-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5557414B2 (en) | Moisturizer, cell activator, and whitening agent | |
JP5062980B2 (en) | Moisturizer, collagen production promoter, whitening agent, antioxidant, and vascular endothelial growth factor production promoter | |
JP4515423B2 (en) | Moisturizer, cell activator, and antioxidant | |
JP4689215B2 (en) | Moisturizer, cell activator, whitening agent, and collagenase inhibitor | |
JP4748962B2 (en) | Moisturizer, cell activator, whitening agent, and antioxidant | |
JP4994684B2 (en) | Moisturizer, cell activator, and antioxidant | |
JP4515425B2 (en) | Moisturizer, cell activator, whitening agent, and antioxidant | |
JP4931452B2 (en) | Moisturizer, cell activator, whitening agent, and antioxidant | |
JP4050727B2 (en) | Moisturizer, cell activator, whitening agent, antioxidant, and skin external preparation | |
JP3754025B2 (en) | Cell activator, antioxidant, and skin external preparation | |
JP4970442B2 (en) | Whitening agent | |
JP4480366B2 (en) | Cell activator, whitening agent, hyaluronic acid production promoter, collagen production promoter, antioxidant, and skin external preparation | |
JP4916150B2 (en) | Moisturizer, cell activator, antioxidant, and skin external preparation, | |
JP4291647B2 (en) | Cell activator, whitening agent, collagen production promoter, antioxidant, and skin external preparation | |
JP5013726B2 (en) | Moisturizer, cell activator, antioxidant, and collagenase inhibitor | |
JP4936754B2 (en) | Moisturizer, cell activator, and collagenase inhibitor | |
JP5009544B2 (en) | Moisturizer, cell activator, antioxidant, and collagenase inhibitor | |
JP2010001286A (en) | External preparation for skin, oral agent, antioxidant, anti-aging agent, and immunostimulator | |
JP4869638B2 (en) | Cell activator, whitening agent, antioxidant, amylase inhibitor, and humectant | |
JP3734222B2 (en) | External preparation for skin, cell activator, and antioxidant | |
JP4018605B2 (en) | Cell activating agent, whitening agent, antioxidant, and skin external preparation | |
JP2007070306A (en) | Moisturizing agent, cell activating agent, bleaching agent, and hyaluronic acid production promoting agent | |
JP4020317B2 (en) | Whitening agent, hyaluronic acid production promoter, collagen production promoter, antioxidant, and skin external preparation | |
JP4050674B2 (en) | Cell activator, whitening agent, hyaluronic acid production promoter, elastin production promoter, antioxidant, and external preparation for skin | |
JP2005089375A (en) | Cell-activating agent, bleaching agent and antioxidant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090707 |
|
A871 | Explanation of circumstances concerning accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A871 Effective date: 20100120 |
|
A975 | Report on accelerated examination |
Free format text: JAPANESE INTERMEDIATE CODE: A971005 Effective date: 20100210 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20100223 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20100401 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100511 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100512 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4515423 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130521 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130521 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140521 Year of fee payment: 4 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |